vaxigrip influenza vaccine 相關
廣告
搜尋結果
Following influenza vaccination, false positive results in serology tests using the ELISA method (blood test) to detect antibodies against HIV1, Hepatitis C and especially HTLV1 have been observed. The Western Blot technique disproves the false-positive ELISA results.
Mechanism of action. VaxigripTetra provides active immunisation against four influenza virus strains (two A subtypes and two B types) contained in the vaccine. VaxigripTetra induces humoral antibodies against the haemagglutinins within 2 to 3 weeks. These antibodies neutralise influenza viruses.
2022年2月25日 · The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2022-2023 influenza season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day Information Meeting on the Composition of Influenza Virus Vaccines, a meeting that is held twice annually.The WHO organizes these ...
For children 6–35 months of age, the correct dosage (volume) is: 0.25 mL for Afluria Quadrivalent. 0.5 mL for Fluarix Quadrivalent. 0.25 mL or 0.5 mL for Fluzone Quadrivalent. 0.5 mL for FluLaval Quadrivalent. For persons 3 years of age and older, the correct dosage is 0.5 mL for most inactivated influenza vaccine products.
VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus HA 60 mcg 0.5 mL suspension for injection Indication(s) Vaxigrip Tetra is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine for:
2018年3月8日 · Vaxigrip Tetra ® (Sanofi Pasteur) is a novel four-strain influenza vaccine belonging to the Vaxigrip ® family of influenza vaccines []. It is a quadrivalent split-virion inactivated influenza vaccine containing the purified HA and NA antigens from the four influenza virus strains recommended by the WHO [ 79 ].
2023年9月5日 · The Government Vaccination Programme (GVP) 2023/24 will be launched on 5 October 2023. The Government will continue to provide free seasonal influenza vaccination and pneumococcal vaccination to the following eligible Hong Kong residents: A) Eligible groups for free seasonal influenza vaccination. B) Eligible elderly aged 65 years or above for ...
